Dow Up 0.07% Nasdaq Up 0.61%

Ariad Pharmaceuticals Inc. (ARIA)

-NasdaqGS
7.29 Up 0.18(2.53%) 4:00PM EST
|After Hours : 7.31 Up 0.02 (0.27%) 7:29PM EST
Prev Close:7.11
Open:7.07
Bid:7.31 x 1000
Ask:7.33 x 300
1y Target Est:8.28
Beta:0.78
Earnings Date:Feb 23 - Feb 27 (Est.)
Day's Range:7.03 - 7.35
52wk Range:3.80 - 9.83
Volume:5,186,955
Avg Vol (3m):6,509,620
Market Cap:1.36B
P/E (ttm):N/A
EPS (ttm):-1.24
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARIAUp 2.53%1.36B
NVSUp 0.55%231.13B
PFEUp 2.07%195.95B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):28.36
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.10
Quarterly EPS Est (Dec-14) :-0.27
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):-0.16

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ARIAD Pharmaceuticals, Inc., an oncology company, is engaged in the discovery, development, and commercialization of medicines for cancer patients. It offers Iclusig (ponatinib), a tyrosine kinase inhibitor for the treatment of adult patients with... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback